What is Bevacizumab?
'''Bevacizumab''' is an anti-angiogenic drug that is used in the treatment of Metastatic [[Renal cell carcinoma]], [[Metastatic breast cancer]], [[Non-small cell lung cancer]], and is also approved in the treatment [[Glioblastoma multiforme]].<ref>{{cite web|url=https://www.medpagetoday.com/neurology/braincancer/14078|title=Bevacizumab Gets Fast-Track Approval for Glioblastoma|date=6 May 2009|website=www.medpagetoday.com}}</ref> ==References== <references /> {{med-stub}} [[Category:Cancer treatment]]